ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
FDA Panel: Engineered Donor Heart Valves Need PMA
Tuesday, October 14, 2014
Submitted by
Source
Source Name: MedPage Today
More than minimally manipulated (MMM) allograft heart valves should be classified as high risk devices, requiring premarket approval including safety and efficacy studies, according to an FDA panel.
Printer-friendly
